서브이미지

About Us

CEO Message

Genofocus is a company that develops new microbiome drugs and develops/produces industrial special enzymes using microbial metabolism.

Genofocus is a company with technology and facilities for maximizing enzyme efficiency and economic mass production by improving microorganisms quickly and accurately, and has its own platform technology required for enzyme production.

Based on core technologies and accumulated know-how, it is developing and producing various industrial enzymes and is further developing into a next-generation microbiome new drug developer.

대표이사 김의중

Kim Eui Joong

CEO

학력 및 주요경력

  • Dr. of Biotechnology at Yonsei University.
    • Microbial display application technology (enzyme, antibody, vaccine, peptide) major.
  • Yonsei University Bio-Industrial Materials Center (Research Institute)
  • Planning secretary and chairman of the Korea Bio-venture Industry Research Association
  • An adjunct professor of biological system at Soongsil University and Biotechnology at Chonnam National University.
  • Genofocus Co., Ltd. (CEO, former head of research institute)
  • GF permentech Co., Ltd. (Former CEO)

Ban Jaegu

Founder & CTO

학력 및 주요경력

  • Doctor of Biotechnology at KAIST.
    • Enzyme and fermentation engineering major.
  • Compiene College of Engineering (France) Bioprocess Engineering Forcedoc.
  • KRIBB (Korea Research Institute of Biotechnology) Senior Research Institute (34 years and 8 months of work)
    • Protein Industry Technology Center Director, Super Bacteria Research Center Director,
    • Bio defense research.
    • Developing microbial display technology for the first time in Korea and responding to super bacteria. Technology development, mucosal immunization vaccine research.
  • Genofocus Co., Ltd. ( General Director of Technology, former CEO)
  • BiomLogic Co., Ltd. (CEO)

Yang Taekho

Director of research institute.

  • KAIST's Ph.D. in Bioscience.
    • Microbial display and enzyme engineering major.
  • LG Chem research team leader.
    • Development of enzyme and biological conversion process.
  • GS Caltex Technology Research Institute.
    • Development of bio-chemical material production technology.

Kim Wonbae

Chairman of the New Drug Advisory Committee.

  • Seoul National University, Ph.D. : Pharmacy
  • Dong-A ST CEO and Vice Chairman.
  • A member of the Presidential Advisory Committee on the Advancement of the Medical Industry.
  • National Science and Technology Commission Policy of the Ministry of Science and Technology. Expert committee member.
  • Regular member of the Korea Institute of Science and Technology.

Lee Jaeyun

CFO

  • Peking University / Kellogg School EMBA
  • USCPA
  • LG Display's management analysis team.
  • Samsung Electronics, Samsung SDI Planning Team.
  • COO, general manager of MELFAS.

Kim Jeonghyeon

Senior researcher.

  • Doctor of Biotechnology at KAIST.
    • Molecular biology major.
  • Purdue University and Korea Research Institute of Biotechnology. Postdoc
  • Samyang Genex's lead researcher.
    • Development of medicinal protein
  • Inje University, Paik Hospital, professor of molecular biology.
    • Biopharmaceutical category.

Jang In ik

Director of Planning.

  • Doctor of Integrated Biology at UTSW Medical Center
  • Researcher at Samsung Life Science Research Institute.
  • Genentech, a postdoctoral researcher at UCSF.
  • Yonsei University Dental Research Professor.
  • Senior researcher at GNT Pharma.
  • Clinical progress control tower

Seo Hyeongwon

Quality control director.

  • Master of Science and Technology at Seoul National University: Genetic Analysis Major
  • Green Cross biological agent production team leader,
    • Biological agents (vaccines), GMP experts.
  • Hanmi Pharmaceutical: The head of the pharmaceutical protein production team
  • LG Life Science.
    • The leader of the biological agent production technology transfer project.

Han Jeongjun

gffermentech CEO

  • Doctor of Biotechnology at KAIST.
    • Enzyme engineering, bio-conversion technology major.
  • Doosan R&D Center/ Doosan Glonet team leader.
    • Physiologically active lipid synthesis, separation, purification process. Development, planning, development of new functional bio materials, Production marketing.

Choi Jongsu

gffermentech CEO

  • Daesang Co., Ltd. - Head of research team at the Central Research Institute.
  • Director of the Korea Bio Research Institute, BASF Korea.
    • Product production technology for bio materials.
  • Head of CJ CheilJedang Bio Research Institute (Sangmu)
    • Production strain and fermentation process development of biomaterials such as amino acids.